MicroRNA 637 (miR-637)

MicroRNA 637 (miR-637) is a primate-specific, non-coding microRNA involved in post-transcriptional gene regulation. It is transcribed as an RNA gene and processed to regulate mRNA stability and translation for various target genes. miR-637 typically acts as a tumor suppressor by inhibiting proliferation, migration, invasion, and promoting apoptosis in cancers such as ovarian, multiple myeloma, and non-small cell lung cancer, often by suppressing targets like PLXNB2, NUPR1, TRIM29, and Osterix (Osx). It also regulates adipogenesis versus osteogenesis in human mesenchymal stem cells, with disruption of its expression tied to conditions like osteoporosis. Downregulation of miR-637 is correlated with poor prognosis in several tumor types and, in pulmonary arterial hypertension, miR-637 is involved in suppressing pathologic cell proliferation and migration. Its primate specificity and diverse regulatory functions make it a focus of research for therapeutic RNA modulation.

Other names

MIR637hsa-miR-637MIRN637

Drug mimics (synthetic oligonucleotides) increase miR-637 function to suppress target oncogene expression, reduce cell proliferation, and promote apoptosis. Inhibitors (anti-miR oligonucleotides) are used experimentally to block endogenous miR-637 function, often leading to increased proliferation or reduced apoptosis in research models.